整形外科用インプラントの世界市場規模：インプラントの種類別、用途別、最終ユーザー別、地域範囲別および予測

整形外科用インプラントの市場規模と予測

整形外科用インプラントの市場規模は、2024年に495億1,000万米ドルと評価され、2026～2032年にかけてCAGR 4.90%で成長し、2032年には700億9,000万米ドルに達すると予測されています。

整形外科用インプラントは、骨折した骨や関節を修復したり支えたりする医療機器です。ネジ、プレート、ロッド、人工関節は、治癒プロセスを助け、機能を回復させるために使用されます。整形外科用インプラントは一般的に、関節の置換、骨折の矯正、脊椎の安定化などの手術に使用されます。

その用途は、外傷、退行性疾患、先天性問題など、幅広い疾患に及んでおり、多様な患者集団に対する治療の成功を保証しています。材料科学とバイオテクノロジーの進歩は、整形外科用インプラントに希望に満ちた未来を指し示しています。

3Dプリンティングインプラントや生理学的変化に適応するスマート材料などの革新的な治療により、治療成績が向上し、より個別化された医療とより良い患者ケアへの道が開かれると期待されています。

整形外科用インプラントの世界市場力学

整形外科用インプラントの世界市場を形成している主要市場力学は以下の通りです。

主要市場促進要因

変形性関節症と筋骨格系障害の有病率の増加：変形性関節症やその他の筋骨格系疾患の頻度は世界的に増加しており、その主要原因は人口の高齢化と肥満率の上昇です。この傾向は、整形外科手術、特に股関節や膝関節の手術などの人工関節置換術の需要を高めます。ヘルスケアシステムがこのニーズに応える中、整形外科用インプラントメーカーは、患者の転帰を改善するための創造的なソリューションを優先しています。例えば、2023年3月、世界保健機関（WHO）は関節関連疾患の急増を報告し、整形外科ヘルスケアへの追加支出を促しました。

インプラントの設計と材料における技術の進歩：低侵襲手術技術や先進生体材料の開発など、整形外科用インプラント技術の革新が市場成長を大きく牽引しています。最近の進歩により、より優れた生体適合性、回復時間の短縮、全体的な性能の向上を実現したインプラントが登場しています。2023年1月、Stryker Corporationは、より高い強度と耐久性を提供する強化された材料で設計された整形外科用インプラントの新シリーズを発売し、市場が技術進歩に注力していることを示しました。

政府の取り組みと投資：ヘルスケアインフラを改善するための最近の政府の取り組みが、整形外科用インプラント事業を後押ししています。例えば、米国保健福祉省は2023年6月、整形外科技術研究を支援し、技術革新を促進する500万米ドルのプロジェクトを発表しました。この資金援助は、技術革新を促進し、治療の選択肢を改善することを目的としており、整形外科セグメントへの投資をより多くの企業に促しています。

スポーツ医療のニーズの高まり：スポーツやフィットネスに参加する人が増えるにつれ、スポーツに関連した怪我の数が増え、整形外科用インプラントの需要が高まっています。各企業は、スポーツ傷害の治療に特化したインプラントや器具を開発することで対応し、このセグメントの市場成長を後押ししています。スミス・アンド・ネフューは、2023年8月にスポーツ医療製品ポートフォリオの拡充を発表し、この急成長セグメントへの取り組み姿勢を示しました。

主要課題

インプラントと手術の高額コスト：整形外科用インプラントや外科治療は高額になる可能性があり、特に貧困国の患者のアクセスが制限されます。この経済的障壁は、ヘルスケアシステムや患者が代替医療を求めたり、重要な治療を完全に見送ったりする可能性があるため、市場拡大の妨げになる可能性があります。

厳しい規制要件：整形外科用インプラント市場は、患者の安全性と製品の有効性を確保するために厳格な規制を受けています。こうした厳しい基準を満たすことは、企業にとって時間と費用がかかるため、製品リリースが遅れたり、開発費が高騰したりして収益性に影響を及ぼす可能性があります。

代替治療との競合：整形外科用インプラント産業は、理学療法、薬剤療法、生物学的療法などの非侵襲的治療との競合に直面しています。疼痛管理や移動に関する懸念に対して患者がより侵襲性の低い選択肢を求めるようになると、外科的インプラントに対する需要が減少し、メーカーは戦略の調整を余儀なくされる可能性があります。

合併症とインプラントの失敗：患者は、感染症、インプラントの不具合、悪い反応などのリスクを理由に整形外科手術を避ける可能性があります。このような危険は、インプラントの設計や材料の継続的な進歩を必要とするため、メーカーの開発負担が増加する一方で、患者の整形外科治療に対する信頼や採用にも影響を及ぼします。

主要動向

インプラントと手術の高額な費用：整形外科用インプラントや外科治療は高額になる可能性があり、特に貧しい国々では患者のアクセスが制限されます。このような経済的障壁は、ヘルスケアシステムや患者が代替医療を求めたり、重要な治療を完全に見送ったりする可能性があるため、市場の拡大を妨げる可能性があります。

厳しい規制要件：整形外科用インプラント市場は、患者の安全性と製品の有効性を確保するために厳格な規制を受けています。こうした厳しい基準を満たすことは、企業にとって時間と費用がかかるため、製品リリースが遅れたり、開発費が高騰したりして収益性に影響を及ぼす可能性があります。

代替治療との競合：整形外科用インプラント産業は、理学療法、薬剤療法、生物学的療法などの非侵襲的治療との競合に直面しています。疼痛管理や移動に関する懸念に対して患者がより侵襲性の低い選択肢を求めるようになると、外科的インプラントに対する需要が減少する可能性があり、メーカーは戦略の調整を余儀なくされます。

合併症とインプラントの失敗：患者は、感染症、インプラントの不具合、悪い反応などのリスクを理由に整形外科手術を避ける可能性があります。このような危険は、インプラントの設計や材料における継続的な進歩を必要とするため、メーカーの開発負担は増大し、同時に患者の整形外科治療に対する信頼や採用にも影響を及ぼします。

目次

第1章 整形外科インプラントの世界市場導入

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 整形外科用インプラントの世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 整形外科用インプラントの世界市場：インプラントの種類別

• 概要
• 短人工関節
• 脊椎インプラント

第6章 整形外科用インプラントの世界市場：用途別

• 概要
• 股関節インプラント
• 膝インプラント
• 脊椎インプラント
• 肩関節インプラント

第7章 整形外科用インプラントの世界市場：最終ユーザー別

• 概要
• 病院
• 外来手術センター（ASC）
• 整形外科クリニック

第8章 整形外科用インプラントの世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• その他
  • ラテンアメリカ
  • 中東

第9章 整形外科インプラントの世界市場の競合情勢

• 概要
• 各社の市場ランキング
• 主要開発戦略

第10章 企業プロファイル

• Johnson & Johnson Services Inc.
• Zimmer Biomet
• Stryker Corporation
• Medtronic plc
• Smith & Nephew plc
• Exactech, Inc.
• B. Braun Melsungen AG.

第11章 付録

• 関連調査

Orthopedic Implants Market Size And Forecast

Orthopedic Implants Market size was valued at USD 49.51 Billion in 2024 and is projected to reach USD 70.09 Billion by 2032, growing at a CAGR of 4.90% from 2026 to 2032.

Orthopedic implants are medical devices that repair or support broken bones and joints. Screws, plates, rods, and prosthetic joints are used to aid in the healing process and restore function. Orthopedic implants are commonly used in surgeries to replace joints, correct fractures, and stabilize the spine.

Their applications cover a wide range of ailments, including trauma, degenerative diseases, and congenital problems, ensuring successful therapy for a diverse patient population. Advancements in materials science and biotechnology point to a hopeful future for orthopedic implants.

Innovations like 3D-printed implants and smart materials that adapt to physiological changes are expected to improve treatment outcomes, paving the path for more personalized medicine and better patient care.

Global Orthopedic Implants Market Dynamics

The key market dynamics that are shaping the global orthopedic implants market include:

Key Market Drivers:

Increasing Prevalence of Osteoarthritis and Musculoskeletal Disorders: The frequency of osteoarthritis and other musculoskeletal problems is increasing worldwide, owing mostly to an ageing population and rising obesity rates. This tendency drives up demand for orthopedic procedures, notably joint replacements such as hip and knee surgery. As healthcare systems respond to this need, orthopedic implant makers prioritize creative solutions to improve patient outcomes. For example, in March 2023, the World Health Organization reported a surge in joint-related disorders, driving additional expenditure in orthopedic healthcare.

Technological Advancements in Implant Design and Materials: Innovations in orthopedic implant technology, including the development of minimally invasive surgical techniques and advanced biomaterials, are significantly driving market growth. Recent advancements have led to implants that offer better biocompatibility, reduced recovery times, and improved overall performance. In January 2023, Stryker Corporation launched a new range of orthopedic implants designed with enhanced materials that provide greater strength and durability, showcasing the market's focus on technological progress.

Governmental Initiatives and Investments: Recent government initiatives to improve healthcare infrastructure have boosted the orthopedic implants business. For example, in June 2023, the United States Department of Health and Human Services announced a $5 million project to support orthopedic technology research, thereby fostering innovation. This funding aims to foster innovation and improve treatment options, encouraging more companies to invest in the orthopedic sector.

Rising Need For Sports Medicine: As more people participate in sports and fitness activities, the number of sports-related injuries rises, driving up demand for orthopedic implants. Companies are reacting by creating specific implants and gadgets for treating sports injuries, hence boosting market growth in this area. Smith & Nephew announced the expansion of its sports medicine product portfolio in August 2023, demonstrating its commitment to serving this burgeoning sector.

Key Challenges:

High Costs of Implants and Procedures: Orthopedic implants and surgical treatments can be costly, limiting access for patients, especially in poor nations. This financial barrier might stymie market expansion, as healthcare systems and patients may seek alternatives or forego critical treatments entirely.

Strict Regulatory Requirements: The orthopedic implants market is closely regulated to ensure patient safety and product efficacy. Meeting these strict criteria can be time-consuming and expensive for businesses, potentially delaying product releases and raising development expenses, affecting profitability.

Competition from Alternative Treatments: The orthopedic implants industry faces competition from non-invasive treatments like physiotherapy, medicine, and biologic therapies. As patients seek less intrusive options for pain management and mobility concerns, demand for surgical implants may decline, forcing manufacturers to adjust their strategy.

Complications and Implant Failures: Patients may avoid orthopedic operations due to risks such as infections, implant failures, and bad reactions. These hazards need ongoing advancements in implant design and materials, which increases the development load for manufacturers while also influencing patient trust and adoption of orthopedic treatments.

Key Trends:

High Costs of Implants and Procedures: Orthopedic implants and surgical treatments can be costly, limiting access for patients, especially in poor nations. This financial barrier might stymie market expansion, as healthcare systems and patients may seek alternatives or forego critical treatments entirely.

Strict Regulatory Requirements: The orthopedic implants market is closely regulated to ensure patient safety and product efficacy. Meeting these strict criteria can be time-consuming and expensive for businesses, potentially delaying product releases and raising development expenses, affecting profitability.

Competition from Alternative Treatments: The orthopedic implants industry faces competition from non-invasive treatments like physiotherapy, medicine, and biologic therapies. As patients seek less intrusive options for pain management and mobility concerns, demand for surgical implants may decline, forcing manufacturers to adjust their strategy.

Complications and Implant Failures: Patients may avoid orthopedic operations due to risks such as infections, implant failures, and bad reactions. These hazards need ongoing advancements in implant design and materials, which increases the development load for manufacturers while also influencing patient trust and adoption of orthopedic treatments.

Global Orthopedic Implants Market Regional Analysis

Here is a more detailed regional analysis of the global orthopedic implants market:

North America:

North America dominates the orthopedic implants market, owing to improved healthcare infrastructure, large healthcare expenditures, and an aging population. The region's well-established medical device industry, combined with large investments in R&D, allows for the speedy introduction of breakthrough devices. Furthermore, the frequency of musculoskeletal problems, particularly among the elderly, drives up demand for orthopedic treatments such joint replacements. Medtronic announced a $50 million investment in August 2023 to enhance its orthopedic product offerings, demonstrating its commitment to meeting the demands of this increasing patient population.

Furthermore, supportive government initiatives and regulatory frameworks improve the market environment in North America. The United States Food and Drug Administration (FDA) has shortened approval processes for orthopedic implants, allowing new technologies to enter the market more quickly. In July 2023, the FDA announced a new initiative to expedite the clearance of innovative orthopedic devices, which is projected to drive further growth in this industry. As a result, the combination of technological breakthroughs, strong healthcare systems, and supportive regulatory frameworks places North America as a market leader for orthopedic implants.

Asia Pacific:

The Asia Pacific area is emerging as the fastest-growing market for orthopedic implants, owing to rising industrialization, urbanization, and increased healthcare investments. The burgeoning middle-class population in nations such as China and India is driving up disposable incomes, increasing demand for modern healthcare services such as orthopedic procedures. Furthermore, the rising frequency of osteoarthritis and sports-related injuries is increasing the demand for orthopedic implants. In May 2023, the Indian government proposed a $3 billion investment in healthcare infrastructure, which is likely to increase access to orthopedic care and, as a result, demand for implants.

Furthermore, the Asia Pacific market is seeing substantial improvements in manufacturing technologies, including as 3D printing and novel materials, which are increasing the availability and customisation of orthopedic implants. Companies are increasingly turning to local manufacturing to cut costs and increase supply chain efficiency. Stryker Corporation, for example, will open a new factory in Singapore in September 2023 to manufacture sophisticated orthopedic implants specifically for the regional market. This relocation underscores not only rising demand, but also the strategic importance of the Asia Pacific area in the worldwide orthopedic implants landscape.

Global Orthopedic Implants Market: Segmentation Analysis

The Global Orthopedic Implants Market is segmented on the basis of By Kind Of Implants, By Application, By Final User and By Geography.

Orthopedic Implants Market, By Kind of Implants

• Short Joint Replacements
• Spinal Implants

Based on Kind Of Implants, the Global Orthopedic Implants Market is segmented into Short Joint Replacements, Spinal Implants. The short joint replacements segment is the dominant category in the global orthopedic implants market, primarily due to the high prevalence of conditions like osteoarthritis and the increasing number of joint replacement surgeries. This segment benefits from advancements in implant technology and materials, leading to improved patient outcomes and higher adoption rates among healthcare providers. The spinal implants segment is the fastest growing segment in the orthopedic implants market, driven by the rising incidence of spinal disorders and an aging population.

Orthopedic Implants Market, By Application

• Hip Implants
• Knee Implants
• Spine implants
• Shoulder Implants

Based on Application, the Global Orthopedic Implants Market is segmented into Hip Implants, Knee Implants, Spine implants, Shoulder Implants. The knee implants segment is the dominant category in the global orthopedic implants market, largely due to the high incidence of knee-related conditions such as osteoarthritis. The increasing number of knee replacement surgeries, supported by advancements in implant technology and materials, drives substantial market demand. The spine implants segment is the fastest growing segment in the orthopedic implants market, fueled by the rising prevalence of spinal disorders and injuries. Innovations in spinal surgery techniques and the development of advanced spinal devices are enhancing treatment options and driving rapid growth in this area.

Orthopedic Implants Market, By Final User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Orthopedic Clinics

Based on Final User, the Global Orthopedic Implants Market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Orthopedic Clinics. The hospitals segment is the dominant category in the global orthopedic implants market, primarily due to the high volume of surgical procedures performed in these facilities. The ambulatory surgical centers (ASCs) segment is the fastest growing segment in the orthopedic implants market, driven by the increasing preference for outpatient procedures. ASCs offer cost-effective solutions, shorter recovery times, and improved patient convenience, leading to a rise in orthopedic surgeries performed in these settings.

Orthopedic Implants Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on the Geography, the Global Orthopedic Implants Market are classified into North America, Europe, Asia Pacific, Rest of the World. North America is the dominant region, owing to its advanced industrial infrastructure and widespread use of precision measurement technologies across industries. The Asia Pacific region is the fastest growing, thanks to rapid industrialization, expanding manufacturing capabilities, and rising investments in technology and infrastructure in emerging economies such as China and India.

Key Players

The "Global Orthopedic Implants Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Johnson & Johnson Services Inc., Zimmer Biomet, Stryker Corporation, Medtronic plc, Smith & Nephew plc, Exactech, Inc. and B. Braun Melsungen AG.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Orthopedic Implants Market Recent Developments
• In July 2023, Zimmer Biomet introduced the Persona IQ knee implant, a smart orthopedic device with inbuilt sensors that provide real-time information about patient healing. This discovery marks a huge step forward in individualized orthopedic therapy, allowing for improved monitoring and customization of rehabilitation methods.
• In August 2023, Medtronic has expanded its orthopedic product portfolio with the introduction of a new generation of sophisticated spinal implants intended to improve patient outcomes. These implants incorporate cutting-edge technology targeted at improving stability and reducing recovery times, demonstrating the company's dedication to meeting the demands of spine surgery patients.
• In September 2023, Stryker launched a new manufacturing facility in Singapore to produce orthopedic implants, mainly knee and hip replacements. This facility intends to strengthen local supply chains and the availability of sophisticated orthopedic treatments in the Asia Pacific area, in response to rising demand for surgical implants.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ORTHOPEDIC IMPLANTS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ORTHOPEDIC IMPLANTS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY KIND OF IMPLANTS

• 5.1 Overview
• 5.2 Short Joint Replacements
• 5.3 Spinal Implants

6 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Hip Implants
• 6.3 Knee Implants
• 6.4 Spine implants
• 6.5 Shoulder Implants

7 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY FINAL USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Ambulatory Surgical Centers (ASCs)
• 7.4 Orthopedic Clinics

8 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East

9 GLOBAL ORTHOPEDIC IMPLANTS MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Johnson & Johnson Services Inc.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Zimmer Biomet
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Stryker Corporation
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Medtronic plc
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Smith & Nephew plc
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Exactech, Inc.
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 B. Braun Melsungen AG.
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments

11 Appendix

• 11.1 Related Research